Anti-CEBP gamma Antibody (Rabbit Polyclonal antibody) General Information
Anti-CEBP gamma Antibody
Reacts with: Human
Human CEBP gamma
Recombinant Human CEBPG / CEBP gamma protein (Catalog#14925-H07E)
Produced in rabbits immunized with purified, recombinant Human CEBPG / CEBP gamma (rh CEBPG / CEBP gamma; Catalog#14925-H07E; P53567; Pro39-Asn147). CEBPG / CEBP gamma specific IgG was purified by Human CEBPG / CEBP gamma affinity chromatography.
Polyclonal Rabbit IgG
Protein A & Antigen Affinity
0.2 μm filtered solution in PBS
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Anti-CEBP gamma Antibody (Rabbit Polyclonal antibody) Validated Applications
|| 0.1-0.2 μg/mL
**********Please Note: Optimal concentrations/dilutions should be determined by the end user.**********
Anti-CEBP gamma Antibody Alternative Names
Anti-GPE1BP Antibody;Anti-IG/EBP-1 Antibody
CEBP gamma Background Information
CEBPG, also known as CEBP gamma, is a transcription factor which belongs to the CEBP family. Members of this family regulate viral and cellular CCAAT/enhancer element-mediated transcription. CEBP proteins contain the bZIP region, which is characterized by two motifs in the C-terminal half of the protein: a basic region involved in DNA binding and a leucine zipper motif involved in dimerization. CEBPG binds to the enhancer element PRE-I of the IL-4 gene. It Might change the DNA-binding specificity of other transcription factors and recruit them to unusual DNA sites.
CCAAT/enhancer binding protein (C/EBP), gamma
Thomassin H. et al., 1992, Nucleic Acids Res. 20 (12): 3091-8. Nishizawa M. et al., 1992, FEBS Lett. 299 (1): 36-8. Williams SC. et al., 1991, Genes Dev. 5 (9): 1553-67. Melchionna R. et al., 2012, J Invest Dermatol. 132 (7): 1908-17.